Nancy Vinh
About Nancy Vinh
Nancy Vinh serves as the Senior Vice President and Head of Clinical Operations at Alpine Immune Sciences, Inc., a position she has held since 2023. With extensive experience in clinical operations across various biopharmaceutical companies, she has held leadership roles at Cellerant Therapeutics, Revolo Biotherapeutics, Portola Pharmaceuticals, CV Therapeutics, and Nile Therapeutics.
Work at Alpine Immune Sciences
Nancy Vinh serves as the Senior Vice President and Head of Clinical Operations at Alpine Immune Sciences, Inc. since 2023. In this role, she oversees clinical development strategies and operations, contributing to the advancement of innovative therapies in the biotechnology sector. Her leadership is focused on ensuring the successful execution of clinical trials and regulatory submissions.
Previous Experience in Clinical Operations
Prior to her current position, Nancy Vinh held several significant roles in clinical operations. She was the Vice President and Head of Clinical Operations at Revolo Biotherapeutics from 2020 to 2023. Before that, she served as Executive Director and Head of Clinical Operations at Portola Pharmaceuticals from 2015 to 2020. Her career also includes positions at Cellerant Therapeutics and CV Therapeutics, where she developed extensive expertise in managing clinical trials and operations.
Education and Expertise
Nancy Vinh studied Molecular Biology at the University of California, Santa Cruz. This educational background provides her with a strong foundation in the scientific principles underlying clinical research and drug development. Her expertise encompasses various aspects of clinical operations, including trial design, regulatory compliance, and project management.
Career Timeline
Nancy Vinh's career in clinical operations spans over two decades. She began as Associate Director of Clinical Operations at CV Therapeutics from 2000 to 2007, followed by roles at Nile Therapeutics Inc as Director of Clinical Operations from 2007 to 2009. She then advanced to Sr. Director at Cellerant Therapeutics from 2010 to 2013, and held various leadership positions at Portola Pharmaceuticals and Revolo Biotherapeutics before joining Alpine Immune Sciences.